148 related articles for article (PubMed ID: 6817372)
1. Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.
Salem SA; King DJ; McDevitt DG
Psychopharmacology (Berl); 1982; 78(2):147-9. PubMed ID: 6817372
[TBL] [Abstract][Full Text] [Related]
2. Induction of microsomal enzyme activity by flupenthixol [proceedings].
Salem SA; King DJ; McDevitt DG
Br J Clin Pharmacol; 1980 Mar; 9(3):313P. PubMed ID: 7362762
[No Abstract] [Full Text] [Related]
3. Enzyme induction and renal function in man.
Ohnhaus EE; Martin J; Kinser J; Colombo JP
Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
[TBL] [Abstract][Full Text] [Related]
4. Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine.
Higuchi T; Nakamura T; Uchino H
Cancer Chemother Pharmacol; 1980; 5(1):55-9. PubMed ID: 6936094
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ginkgo biloba extract on microsomal enzyme induction.
Duche JC; Barre J; Guinot P; Duchier J; Cournot A; Tillement JP
Int J Clin Pharmacol Res; 1989; 9(3):165-8. PubMed ID: 2744909
[TBL] [Abstract][Full Text] [Related]
6. Effect of pesticide exposure on human microsomal enzyme induction.
Uppal R; Sharma PR; Chaudhury RR
Hum Toxicol; 1982 Mar; 1(2):155-8. PubMed ID: 7173896
[TBL] [Abstract][Full Text] [Related]
7. Microsomal enzyme induction by permethrin in rats.
Anadon A; Diez MJ; Sierra M; Sanchez JA; Teran MT
Vet Hum Toxicol; 1988 Aug; 30(4):309-12. PubMed ID: 2902710
[TBL] [Abstract][Full Text] [Related]
8. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
Maddocks JL; Wake CJ; Harber MJ
Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
[TBL] [Abstract][Full Text] [Related]
9. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
Moreland TA; Park BK; Rylance GW
Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
[TBL] [Abstract][Full Text] [Related]
10. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.
Luoma PV; Sotaniemi EA; Arranto AJ
Scand J Clin Lab Invest; 1983 Dec; 43(8):671-5. PubMed ID: 6665516
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease.
Wensing G; Ohnhaus EE; Hoensch HP
Clin Pharmacol Ther; 1990 Jun; 47(6):698-705. PubMed ID: 2113450
[TBL] [Abstract][Full Text] [Related]
12. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Kong DS; Yeo SH
Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
[TBL] [Abstract][Full Text] [Related]
13. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Dencker SJ; Lepp M; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
[TBL] [Abstract][Full Text] [Related]
14. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
[TBL] [Abstract][Full Text] [Related]
15. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
[TBL] [Abstract][Full Text] [Related]
16. Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].
Crow TJ; Johnstone EC
Br J Pharmacol; 1977 Mar; 59(3):466P. PubMed ID: 14758
[No Abstract] [Full Text] [Related]
17. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
Byrne E; Harman AW; Frewin DB; Hallpike JF
Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
[TBL] [Abstract][Full Text] [Related]
18. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
[TBL] [Abstract][Full Text] [Related]
19. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
Cookson IB
Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
